SIVE · Sivers Semiconductors AB (publ)

SIVE has highest possible upside, potentially becoming the next LITE, with laser chokepoints enabling downstream TAM expansion and vertical integration.

Sivers is undervalued relative to its private market peers in the silicon photonics space, as it provides upstream lasers for frontier CPO companies valued at $4B-15B+. Upcoming M&A, NASDAQ listing, and ETF inflows could close the valuation gap.

SIVE is at an early stage with upcoming institutional inflows from Blackrock, Vanguard, MSCI, NASDAQ next week and a NASDAQ listing soon, positioning it for significant growth similar to early AXTI or LITE.

$SIVE is extremely early; institutional capital is about to enter due to index inflows next week and subsequent NASDAQ listing.

Sivers is the largest beneficiary of NASDAQ index inclusion (OMX Stockholm) and US-Sweden government collaboration, leading to passive institutional inflows from Vanguard/Blackrock and fundamental support from CHIPS Act awards.

SIVE has successfully penetrated the design systems of many top CPO architectures, partnering with industry leaders like Ayar, Lightelligence, Lightmatter, and Celestial.

SIVE, Foci, Shunsin, and MSSCorp are top picks for co-packaged optics (CPO), expected to grow significantly over the next 2 years.

AI capex projected to reach $3-4 trillion annually by 2030, benefiting companies controlling key AI supply chain nodes like photonics, lasers, epiwafers, neoclouds, and memory.

SIVE is a high-conviction long due to strong positioning with hyperscaler suppliers, massive TAM expansion in pluggables and CPO, validated demand, confirmed moat, CHIPS Act funding, management execution, and upcoming passive inflows.

Sivers is a chokepoint and bottleneck for leading CPO players due to its architecturally unique CW lasers, with volume ramp expected in 2027, making current valuation metrics misguided.

US government backing via CHIPS Act funding and involvement in defense supply chains and US-Sweden tech MOU positions SIVE for growth.

Sivers supplies lasers for CPO and 1.6T, positioning to become next Lumentum by expanding into optical engines and transceiver IP during CPO supercycle.

Sivers is the 'Kingmaker' in photonics CPO, with NASDAQ listing proceeds fueling M&A to expand TAM and revenue, leveraging their expertise in early-stage companies that became billion-dollar successes.

Sivers is the key laser supplier for CPO, with partnerships across major optical and ASIC companies, positioning it as a critical player in the growing CPO market.

SIVE is a crown jewel photonics company poised for growth from the CPO supercycle, with Jabil mass producing 1.6T LRO for hyperscalers by H1 2027, MSCI inclusion, and NASDAQ listing, while local shorts are trapped losing money.

Sivers has a strong track record of serving future high-value customers in optical IP. With a NASDAQ listing and recent growth, they now have funding to acquire the optical IP they need, unlocking significant downstream potential.

Jabil confirms earlier than expected mass production for 1.6T optical transceivers with Sivers lasers, with extreme demand and a relatively dramatic moat, implying uncapped demand and significant revenue potential relative to market cap.

Sivers Semiconductors (SIVE) has high short interest and near-term catalysts (MSCI inflow, NASDAQ listing, US CHIPS Act) alongside a long-term revenue supercycle from optical connectivity partners, likely causing a short squeeze and driving the stock higher.

Sivers Semiconductors could achieve $10B+ market cap by 2027 through strategic moves similar to Lumentum's growth path, including NASDAQ listing, institutional investment, IP acquisition, and expansion into pluggable transceivers and ELS for CPO market.

SIVE will go higher due to MSCI inclusion, CHIPS ACT funding, and government backing as a critical chokepoint.

US government awards SIVE $6.6M CHIPS Act grant, contradicting negative Swedish sentiment.

Long-term holdings in photonics infrastructure (lasers, glass substrates, US supply chain, epiwafers) with asymmetric risk/reward.

POET's $50M purchase from Lumilens and scaling to $500M is bullish for Sivers, as POET ramps H2 2026 with SIVE, making SIVE the laser chokepoint for midstream demand.

Sivers Semiconductors is positioned to benefit from optical AI connectivity via CPO and pluggable transceivers, leveraging CW laser bottleneck, Win Semi capacity lock-in, and volume production scaling H2 2026.

Expect NASDAQ listing to accelerate due to strong management team (UC Berkeley CEOs, LITE executives) and American institutional investors controlling the cap table.

CPO (co-packaged optics) is a massive thematic opportunity, with TAM growing from $0 to $91B, favoring non-US players like SIVE, SOI, and Asian component/foundry companies, as US legacy players face cannibalization.

Sivers Semiconductors owns the CW laser chokepoint for CPO, currently valued at $1.4B before CPO adoption, with potential for massive growth similar to LITE and AAOI which owned laser chokepoints for earlier technologies.

Sivers Semiconductors is undervalued due to limited Swedish market; NASDAQ listing and 2.5% dilution are bullish catalysts that could drive market cap to $3B+.

European media dismissed these as meme stocks/overvalued, but structural growth from AI, SiPH, CPO is driving record performance, and they continue to deliver triple-digit returns.

Sivers is a compelling CPO-related long with heavy short interest that could lead to a short squeeze as CPO ramps up.

SIVE is the most compelling laser company due to CPO scaling up in 2027.

SIVE can become the next Lumentum by owning the laser chokepoint and acquiring downstream IP, scaling to $10B+ next year and $40B+ by 2028.

SIVE is the most compelling CPO exposure, with growth driven by photonics.

Sivers Semiconductors is a primary/sole laser supplier for Jabil's 1.6T LRO and Ayar Labs' volume ramp, with mass production in 3-10 months, positioning for significant revenue growth.

Sivers lasers are the primary/sole source for multiple high-value photonics companies that command $5-$15B+ valuations, making SIVE extremely undervalued by comparison.

Index fund buying by Vanguard and Blackrock creates pure buying pressure on SIVE float, with expected additional inflows next week.

Sivers (SIVE) is a key upstream laser supplier for 4D FMCW lidar used in robotics and autonomous driving, with near-term revenue from Nvidia's self-driving architectures and long-term exposure via humanoid robots.

AAOI is a pure manufacturing scale play with a bullish revenue ramp; SIVE has unique IP used by major CPO hyperscaler suppliers, with potential for vertical integration.

High conviction in SIVE due to strong executive team, IP acquisition strategy, CHIPS ACT support, and partnerships with NOK and AAPL validating IP moat; recent market interest provides needed funding.

Sivers Semiconductors is gaining multiple positive catalysts: MSCI listing, CHIPS Act funding, strong Jabil demand, potential Apple Watch adoption, new M&A-focused board members, and upcoming Nasdaq listing.

Multiple upcoming catalysts (MSCI inclusion, NASDAQ uplisting, earnings with new partners, JBL demand for 1.6T LRO, M&A) combined with high short interest (17%+ of float) create a painful environment for short sellers.

SIVE is likely the sole source for JBL's specific 1.6T LRO due to architectural uniqueness.

SIVE is part of the Ayar/AlChip/Amazon Trainium supply chain, which is more bullish than POET's $50M to $500M purchase order.

SIVE's optical side delivered positive updates including volume ramp, TAM expansion, new hyperscaler suppliers, and secured capacity.

Management is executing extremely well, reaffirms satisfaction with holding SIVE.

Listing in MSCI Global Small Cap Index will drive passive inflows as market cap grows, with rebalancing on May 29th.

Dilution resolved, positive for SIVE.

Sivers Semiconductors is undervalued given its position as a laser supplier to major tech companies for CPO/1.6T optical transceivers, with massive TAM growth ($0 to $91B in two years) and potential for vertical integration, leading to significant market cap increase.

SIVE likely becomes direct laser supplier to Marvell for Celestial platform after Marvell dropped Poet, as SIVE fits Celestial specs.

Potential dilution from a 25 million share ATM offering, with uncertainty about timing.

SIVE is actively taking steps to list on Nasdaq, not just considering it.

$SIVE supplies light source for POET's ELS, and Nvidia validation of POET's ecosystem is a huge catalyst for $SIVE.

$SIVE is an upstream laser supplier for CPO and Silicon Photonics, likely embedded in hyperscaler supply chains (AMZN, MSFT, META, GOOGL) via partners like Ayar, POET, Enablence. With ~$200M market cap, it is an undiscovered opportunity akin to early $LITE.

Markets are underestimating SIVE's future prospects.

SIVE did not meet market cap, volume, or listing thresholds for US private equity firms, indicating a potential barrier to institutional interest.

$SIVE is a compelling CPO exposure stock at $2.3B market cap, significantly undervalued compared to peers like AAOI, Furukawa, MTSI, Sumitomo, COHR, and LITE (all tens of billions).

Slight correction due to standard transfer of shares to US investors before the CPO supercycle; high conviction in SIVE moving forward.

SIVE is promising exposure to the upcoming CPO supercycle.

SIVE is undervalued due to Swedish media bias; company has a secret hyperscaler deal and is positioned to benefit from CPO market growth, potentially reaching $10B+ market cap.

Coherent's CEO reaffirmed CPO as a massive revenue driver, with initial scale-out revenue in H2 2026 and scale-up in H2 2027, suggesting frontrunning CPO names before market pricing.